Price History
Feb 9, 2026 — Aug 23, 2026Investment Snapshot
- Trading 33% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 7/9 — financially strong with improving fundamentals
- ROE of 6.2% — below-average profitability
- Revenue growing at 9% annually
National Vision Holdings, Inc. - Common Stock (EYE) is a Healthcare company operating in Ophthalmic Goods, listed on the NASDAQ , with a market capitalisation of $1.4 billion . Key value metrics: P/E ratio 25.4, P/B ratio 1.58, Piotroski F-Score 7 out of 9 (strong financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
National Vision Holdings, Inc. - Common Stock — Fundamental Analysis Summary
National Vision Holdings, Inc. - Common Stock (EYE) is currently trading 33% above its Graham Number of $13.41, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries an elevated trailing P/E ratio of 25.4x.
On financial health, EYE shows a strong Piotroski F-Score of 7/9, indicating improving fundamentals across profitability, leverage, and efficiency, and modest return on equity of 6.2% (sector average: -20.1%), and minimal leverage with a debt-to-equity ratio of 0.26.
StockPik's composite Value Score for EYE is 85/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
EYE shows revenue growing at 9% year-over-year, with earnings growing at 204%.